Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 100 Total
GAM - General American Investors Co., Inc. - Stock Price Chart
TickerGAM [NYSE]
CompanyGeneral American Investors Co., Inc.
CountryUSA
IndustryClosed-End Fund - Equity
Market Cap1.35BEPS (ttm)11.67
P/E4.23EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-66.35%
P/S50.77EPS next 5Y-
P/B0.86EPS Q/Q52.80%
Dividend1.12%Sales Q/Q10.20%
Insider Own8.42%Inst Own30.21%
Insider Trans-1.78%Inst Trans-
Short Float0.03%Earnings-
Analyst Recom-Target Price-
Avg Volume22.18K52W Range37.44 - 49.49
General American Investors Company, Inc. is a publicly owned investment manager. The firm invests in the public equity markets of United States. It invests in growth stocks of companies. It makes investments in Information Technology, Financials, Consumer Staples, Consumer Discretionary, Retailing, Communication Services, Industrials, Health Care, Energy and Materials. The firm employs fundamental analysis with a bottom-up stock picking approach to make its investments. It conducts in-house research to make its investments. General American Investors Company, Inc. was founded in 1927 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stark Eugene SVP Administration/CCO/PFOJun 14 '24Buy24.761,97348,84312,000Jun 17 10:20 AM
Stark Eugene SVP Administration/CCO/PFOMay 29 '24Buy45.3226211,87510,027May 30 04:55 PM
Priest Jeffrey WPresident & CEOMay 23 '24Buy24.672,19254,0779,392May 23 05:20 PM
1975 TRUST FBO ALTSCHUL ARTHURTrustee is a directorMay 22 '24Sale24.636,397157,5590May 23 10:44 AM
ALTSCHUL ARTHUR G JRDirectorMay 22 '24Sale24.636,397157,55926,400May 23 10:58 AM
FFIN - First Financial Bankshares, Inc. - Stock Price Chart
TickerFFIN [NASD, RUT]
CompanyFirst Financial Bankshares, Inc.
CountryUSA
IndustryBanks - Regional
Market Cap4.01BEPS (ttm)1.40
P/E20.12EPS this Y4.66%
Forward P/E18.14EPS next Y4.99%
PEG2.01EPS past 5Y4.67%
P/S6.04EPS next 5Y10.00%
P/B2.67EPS Q/Q1.61%
Dividend2.64%Sales Q/Q20.19%
Insider Own4.11%Inst Own71.31%
Insider Trans0.25%Inst Trans-0.56%
Short Float6.20%EarningsApr 18/a
Analyst Recom3.00Target Price31.40
Avg Volume439.06K52W Range22.84 - 33.15
First Financial Bankshares, Inc. is a holding company, which engages in the provision of financial and community banking services. It offers mortgage loans, savings and checking accounts, auto and equity loans, online and mobile banking, investment and trust management, and retirement plans. The company was founded in 1956 and is headquartered in Abilene, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TROTTER JOHNNYDirectorJun 14 '24Buy27.791,00027,790943,371Jun 17 09:55 AM
Denny Michael B.DirectorJun 06 '24Buy28.893,500101,115108,085Jun 07 02:44 PM
Davis Sally PopeDirectorJun 06 '24Buy28.751,80051,7501,800Jun 06 02:52 PM
Hickox Michelle SEVP/CFOMay 23 '24Buy29.701,00029,70019,363May 24 03:24 PM
Hickox Michelle SEVP/CFOMay 15 '24Buy31.251,00031,25018,363May 16 04:13 PM
SNDX - Syndax Pharmaceuticals Inc - Stock Price Chart
TickerSNDX [NASD, RUT]
CompanySyndax Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap1.62BEPS (ttm)-3.22
P/E-EPS this Y-21.33%
Forward P/E-EPS next Y18.07%
PEG-EPS past 5Y-0.41%
P/S-EPS next 5Y-
P/B3.29EPS Q/Q-43.44%
Dividend-Sales Q/Q-
Insider Own5.80%Inst Own101.48%
Insider Trans0.03%Inst Trans7.03%
Short Float12.05%EarningsMay 08/b
Analyst Recom1.23Target Price34.33
Avg Volume1.01M52W Range11.22 - 25.34
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goldan Keith A.Chief Financial OfficerJun 14 '24Buy20.031,25025,03752,623Jun 17 09:26 AM
Morrison BriggsDirectorAug 09 '23Option Exercise8.7752,855463,53870,691Aug 10 06:50 AM
Morrison BriggsDirectorAug 09 '23Sale18.2752,855965,40217,836Aug 10 06:50 AM
Meury WilliamDirectorAug 02 '23Option Exercise8.0283,000665,25083,000Aug 03 09:12 AM
Meury WilliamDirectorAug 02 '23Sale20.4683,0001,697,81048,000Aug 03 09:12 AM
TURN - 180 Degree Capital Corp - Stock Price Chart
TickerTURN [NASD]
Company180 Degree Capital Corp
CountryUSA
IndustryAsset Management
Market Cap37.00MEPS (ttm)-1.37
P/E-EPS this Y68.50%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S672.82EPS next 5Y30.00%
P/B0.74EPS Q/Q-
Dividend-Sales Q/Q-92.10%
Insider Own8.90%Inst Own24.50%
Insider Trans12.27%Inst Trans0.37%
Short Float0.07%EarningsMay 13/a
Analyst Recom-Target Price-
Avg Volume11.66K52W Range3.65 - 4.97
180 Degree Capital Corp. is a publicly owned corporate pension plan sponsor. It primarily provides its services to pension and profit sharing plans. The firm is a large advisory firm which provides portfolio management for pooled investment vehicles, pension consulting services. It manages separate client focused equity and balanced funds. It invests in exchange-traded equity securities, non exchange-traded equity securities, cash and cash equivalents and assets of the adviser that are primarily receivables and prepaid expenses. The firm conducts in-house research to make investments. The firm was formerly known as Harris & Harris Group, Inc. 180 Degree Capital Corp. was founded in 1981 and is based in Montclair, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wolfe Daniel BPresidentJun 14 '24Buy3.691,5005,542247,500Jun 17 09:01 AM
Rendino KevinChairman and CEOJun 13 '24Buy3.7613,51750,844773,499Jun 17 09:08 AM
Gift Alicia MTreasurer, SecretaryJun 13 '24Buy3.741,0003,74045,465Jun 14 08:45 AM
Rendino KevinChairman and CEOJun 10 '24Buy3.783,95714,957759,982Jun 12 04:25 PM
Wolfe Daniel BPresidentJun 05 '24Buy3.781,0003,780246,000Jun 06 08:52 AM
AVXL - Anavex Life Sciences Corporation - Stock Price Chart
TickerAVXL [NASD, RUT]
CompanyAnavex Life Sciences Corporation
CountryUSA
IndustryBiotechnology
Market Cap328.40MEPS (ttm)-0.50
P/E-EPS this Y13.33%
Forward P/E-EPS next Y-23.08%
PEG-EPS past 5Y-9.03%
P/S-EPS next 5Y-
P/B2.40EPS Q/Q23.60%
Dividend-Sales Q/Q-
Insider Own3.06%Inst Own37.77%
Insider Trans-2.47%Inst Trans-1.98%
Short Float26.59%EarningsMay 09/b
Analyst Recom1.00Target Price27.50
Avg Volume1.15M52W Range3.25 - 10.45
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Donhauser Peter D.O.DirectorJun 14 '24Buy3.642,83510,3195,000Jun 17 07:30 AM
Thomas SteffenDirectorMay 15 '24Buy4.525,00022,6005,000May 17 06:01 AM
MISSLING CHRISTOPHER UPresident and CEOMar 28 '24Option Exercise1.3273,38096,8621,323,590Apr 01 06:00 PM
MISSLING CHRISTOPHER UPresident and CEOMar 28 '24Sale5.1173,380374,9721,250,210Apr 01 06:00 PM
MISSLING CHRISTOPHER UPresident and CEOJun 29 '23Option Exercise1.60232,000371,2001,250,210Jun 30 08:00 PM
ALXO - Alx Oncology Holdings Inc - Stock Price Chart
TickerALXO [NASD, RUT]
CompanyAlx Oncology Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap361.05MEPS (ttm)-3.71
P/E-EPS this Y24.01%
Forward P/E-EPS next Y1.22%
PEG-EPS past 5Y-50.98%
P/S-EPS next 5Y-
P/B2.12EPS Q/Q3.90%
Dividend-Sales Q/Q-
Insider Own42.84%Inst Own56.46%
Insider Trans-0.54%Inst Trans1.06%
Short Float9.78%EarningsMay 09/a
Analyst Recom1.29Target Price21.00
Avg Volume672.87K52W Range3.94 - 17.83
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GARCIA PETER SCHIEF FINANCIAL OFFICERJun 13 '24Buy8.5312,000102,338122,348Jun 17 07:29 AM
Pons JaumePRESIDENT & CSOJun 04 '24Option Exercise0.9920,00019,800624,205Jun 06 04:06 PM
Pons JaumePRESIDENT & CSOJun 04 '24Sale8.4320,000168,652604,205Jun 06 04:06 PM
Randolph SophiaCHIEF MEDICAL OFFICERMay 13 '24Sale15.9412,000191,339330,349May 15 04:30 PM
Pons JaumePRESIDENT & CSOMay 06 '24Option Exercise0.9920,00019,800624,205May 08 05:31 PM
BCDA - BioCardia Inc. - Stock Price Chart
TickerBCDA [NASD]
CompanyBioCardia Inc.
CountryUSA
IndustryBiotechnology
Market Cap6.44MEPS (ttm)-6.97
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y30.13%
P/S13.71EPS next 5Y-
P/B-EPS Q/Q48.01%
Dividend-Sales Q/Q-14.06%
Insider Own29.13%Inst Own7.13%
Insider Trans-3.10%Inst Trans-
Short Float1.63%EarningsMay 14/a
Analyst Recom2.00Target Price60.00
Avg Volume124.78K52W Range3.20 - 43.80
BioCardia, Inc. is a clinical-stage biotherapeutic company. It engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Altman PeterPresident and CEOJun 14 '24Buy3.525001,76038,745Jun 17 07:00 AM
Altman PeterPresident and CEOJun 10 '24Buy3.361,0003,36038,245Jun 12 07:00 AM
Altman PeterPresident and CEOApr 19 '24Buy0.372,7501,013558,697Apr 19 05:38 PM
Altman PeterPresident and CEOMar 28 '24Buy0.39500195555,947Mar 28 07:33 PM
Altman PeterPresident and CEOFeb 13 '24Buy0.46108,10850,000555,447Feb 15 07:00 AM
REFR - Research Frontiers Inc. - Stock Price Chart
TickerREFR [NASD]
CompanyResearch Frontiers Inc.
CountryUSA
IndustryElectronic Components
Market Cap60.34MEPS (ttm)-0.06
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y11.25%
P/S62.20EPS next 5Y30.00%
P/B19.57EPS Q/Q5.04%
Dividend-Sales Q/Q26.27%
Insider Own15.99%Inst Own9.42%
Insider Trans0.14%Inst Trans0.90%
Short Float1.28%EarningsMay 09/a
Analyst Recom1.00Target Price3.00
Avg Volume54.03K52W Range0.90 - 2.41
Research Frontiers, Inc. engages in development, licensing and commercialization of suspended particle device (SPD) light-control technology for automobiles, homes, buildings, aircraft, boats, exhibition and display applications markets. It develops and licenses technologies to other companies that manufactures and markets SPD-smart chemical emulsion or light-control film made from chemical emulsion, lamination services and electronics to power end-products incorporating the film, skylights and sunroofs. The company was founded by Robert L. Saxe in October 1965 and is headquartered in Woodbury, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kaganowicz AlexanderDirectorJun 14 '24Buy1.942,0003,880164,923Jun 17 06:30 AM
Daigle DarrylDirectorJun 07 '24Buy1.744,3007,48233,926Jun 10 06:04 AM
Daigle DarrylDirectorFeb 07 '24Buy1.001,0001,0004,269Feb 08 05:50 PM
Daigle DarrylDirectorDec 11 '23Buy0.977,7507,518217,192Dec 12 08:45 AM
Daigle DarrylDirectorOct 02 '23Buy1.055005253,269Oct 03 09:18 AM
GLSI - Greenwich LifeSciences Inc - Stock Price Chart
TickerGLSI [NASD]
CompanyGreenwich LifeSciences Inc
CountryUSA
IndustryBiotechnology
Market Cap205.69MEPS (ttm)-0.72
P/E-EPS this Y-8.70%
Forward P/E-EPS next Y6.67%
PEG-EPS past 5Y-36.91%
P/S-EPS next 5Y-
P/B40.15EPS Q/Q-16.26%
Dividend-Sales Q/Q-
Insider Own54.60%Inst Own5.68%
Insider Trans3.53%Inst Trans-23.11%
Short Float3.33%EarningsMay 20
Analyst Recom1.00Target Price36.00
Avg Volume32.59K52W Range7.58 - 21.44
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patel SnehalCEO and CFOJun 13 '24Buy14.30174,8252,499,9985,525,602Jun 17 06:10 AM
Patel SnehalCEO and CFOApr 01 '24Buy19.083,00057,2405,350,777Apr 03 06:10 AM
Patel SnehalCEO and CFOMar 22 '24Buy19.982,50049,9505,347,777Mar 26 06:05 AM
Patel SnehalCEO and CFOMar 20 '24Buy17.681,50026,5205,345,277Mar 22 06:02 AM
Patel SnehalCEO and CFOMar 05 '24Buy12.4930,500380,9455,343,777Mar 07 06:05 AM
OPAD - Offerpad Solutions Inc - Stock Price Chart
TickerOPAD [NYSE]
CompanyOfferpad Solutions Inc
CountryUSA
IndustryReal Estate Services
Market Cap128.04MEPS (ttm)-2.76
P/E-EPS this Y69.36%
Forward P/E-EPS next Y57.62%
PEG-EPS past 5Y-
P/S0.13EPS next 5Y-
P/B1.45EPS Q/Q-282.51%
Dividend-Sales Q/Q-53.19%
Insider Own43.37%Inst Own34.63%
Insider Trans1.20%Inst Trans-24.92%
Short Float5.61%EarningsMay 06/a
Analyst Recom3.00Target Price7.30
Avg Volume45.40K52W Range4.50 - 15.19
Offerpad Solutions, Inc. engages in the operation of a real estate platform that enables consumers to seamlessly buy and sell properties using a mobile device. The company was founded by Brian Bair in July 2015 and is headquartered in Chandler, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sella Roberto MarcoDirectorJun 14 '24Buy4.907,69837,7203,138,883Jun 14 07:52 PM
Sella Roberto MarcoDirectorJun 13 '24Buy4.9010,00049,0003,131,185Jun 14 07:52 PM
Sella Roberto MarcoDirectorJun 12 '24Buy4.902,73513,4023,121,185Jun 14 07:52 PM
Sella Roberto MarcoDirectorJun 11 '24Buy4.8814,38670,1963,118,450Jun 11 07:57 PM
Sella Roberto MarcoDirectorJun 10 '24Buy4.8915,10473,8103,104,064Jun 11 07:57 PM
12345678910